BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2412188)

  • 1. [Experience in the use of the tumor markers CEA, GICA and TPA in the postoperative monitoring of colorectal neoplasms].
    Morelli M; Nardi M; Valle M; Balducci D; Serafini D; Bernardini P
    Minerva Med; 1985 Sep; 76(34-35):1529-31. PubMed ID: 2412188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
    Tappero G; Piantino P; Cerchier A; Pecchio F
    Minerva Med; 1985 Apr; 76(16):765-70. PubMed ID: 2582313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
    Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M
    Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of tumour markers (CEA, TPA, CA 19-9) in colon and rectum carcinomas.
    Cangemi V; Volpino P; Fiori E; Giammarco A; Piat G
    J Nucl Med Allied Sci; 1987; 31(2):189-93. PubMed ID: 3476692
    [No Abstract]   [Full Text] [Related]  

  • 5. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
    Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL
    Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases.
    Putzki H; Ledwoch J; Student A; Jablonski M; Heymann H
    J Surg Oncol; 1988 Feb; 37(2):133-5. PubMed ID: 3278167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of serum levels of carcinoembryonic antigen, CEA, and gastrointestinal cancer antigen, GICA or CA 19-9, for preoperative staging and postoperative monitoring of patients with colorectal carcinoma.
    Szymendera JJ; Nowacki MP; Kozłowicz-Gudzińska I; Kowalska M
    Dis Colon Rectum; 1985 Dec; 28(12):895-9. PubMed ID: 3864628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of tumor markers in patients with colorectal cancer].
    Naritaka Y; Ogawa K; Matsumoto N; Hosokawa T; Kikuchi T; Koyama N; Haga S; Kajiwara T; Sakakibara N
    Gan No Rinsho; 1987 Aug; 33(10):1274-80. PubMed ID: 2444727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparative evaluation of tumor markers (TPA and CEA) in various malignant neoplasms at an advanced stage].
    Meregalli M; Antoniazzi V; Torchio G; Colombo E; Bocchi M; Sonzini E; Lino S
    Minerva Med; 1989 Apr; 80(4):345-7. PubMed ID: 2725935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the tumor markers CEA, TPA, and CA 19-9 in colorectal carcinoma.
    Putzki H; Student A; Jablonski M; Heymann H
    Cancer; 1987 Jan; 59(2):223-6. PubMed ID: 3467817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up of colorectal cancer resected for cure. An experience with CEA, TPA, Ca 19-9 analysis and second-look surgery.
    Fucini C; Tommasi SM; Rosi S; Malatantis G; Cardona G; Panichi S; Bettini U
    Dis Colon Rectum; 1987 Apr; 30(4):273-7. PubMed ID: 3470172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carcinoembryonic antigen, CEA, in colorectal cancer. An insensitive marker which may be excluded from follow-ups].
    Wählby L
    Lakartidningen; 1997 Apr; 94(18):1716-8. PubMed ID: 9182180
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical utility of tumor markers in gastric and colon cancer].
    Ogawa K; Naritaka Y; Koyama N; Ohtani Y; Kawata H; Yagawa H; Kajiwara T; Sakakibara N
    Gan No Rinsho; 1985 May; 31(6 Suppl):638-47. PubMed ID: 3861884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
    Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
    Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tissue polypeptide antigen (TPA) as a tumor marker in disorders of the digestive tract: comparison with CEA].
    Piantino P; Tappero G; Cerchier A; Pecchio F; Tridico F; Cattaneo U
    Minerva Med; 1986 Apr; 77(16):617-20. PubMed ID: 3703360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor-associated markers in malignant lung neoplasms].
    Piancino G; Racca P; Rayneri W; Piantino P; Cerchier A; Pecchio F
    Minerva Med; 1986 Jan; 77(1-2):19-25. PubMed ID: 3945411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of tissue polypeptide antigen (TPA) and carcino embryonic antigen (CEA) in different types of cancer.
    Falcone F; Sabbatani S; Fini A; Turba E; Magri P; D'Ales A
    Nucl Med Commun; 1985 May; 6(5):299-304. PubMed ID: 4034127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue polypeptide antigen - a new tumour marker?
    Wagner W; Husemann B; Becker H; Groitl H; Koerfgen HP; Hammerschmidt M
    Aust N Z J Surg; 1982 Feb; 52(1):41-3. PubMed ID: 6951549
    [No Abstract]   [Full Text] [Related]  

  • 19. Simultaneous radioimmunoassay for carcinoembryonic antigen (CEA) and alpha-fetoprotein (alphaFP) in neoplasms of the gastro-intestinal tract.
    McIntire KR; Waldmann TA; Go VL; Moertel CG; Ravry M
    Ann Clin Lab Sci; 1974; 4(2):104-8. PubMed ID: 4819750
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of carcinoembryonic antigen (CEA) in the diagnosis and postoperative monitoring of patients with colorectal cancer].
    Catania G; Basile F; Cardì F; Azzarello G; Mazzarino C; Campo M; Giovinetto A
    Minerva Chir; 1981 May; 36(9):569-80. PubMed ID: 6789243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.